A discussion on how real-world data and patient involvement can boost outcomes
Advancements in cell and gene therapies offer an unprecedented level of hope for patients, but present essential differences from the experience with conventional medicines. These unique challenges exist across multiple aspects of the patient journey, from clinical trial recruitment to long-term follow-up, including access to these transformative therapies.
In this panel, patient advocates and industry experts share their experiences, challenges and potential solutions.